In high-risk patients with pulmonary arterial hypertension, Merck ’s fusion protein therapeutic Winrevair reduced the ...

Jon Pritti Jon Pritti, Partner, Healthcare Technology NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Solomon Partners, a ...

ADC Therapeutics (NYSE:ADCT – Free Report) had its target price reduced by Guggenheim from $10.00 to $7.00 in a report published on Monday,Benzinga reports. They currently have a buy rating on the ...

Corebridge Financial Inc. cut its position in shares of Teradata Co. (NYSE:TDC – Free Report) by 4.7% during the 4th quarter, ...

GLO's performance has been disappointing, underperforming both the S&P 500 and MSCI World Index over the past five months.

“The new age arrives on no specific day; it creeps up slowly, and then pounces suddenly.” ...